During the past decade, Affecta Pskyiatrimottagning conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Affecta Pskyiatrimottagning" are "Depressive Disorder, Major" (2 trials). Many other conditions were trialed in "Affecta Pskyiatrimottagning" in a lesser frequency.

Most popular intervention types in "Affecta Pskyiatrimottagning" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Esketamine 28 mg" (1 trials), "Esketamine 56 mg" (1 trials), "Esketamine 84 mg" (1 trials), "Placebo" (1 trials) and "Quetiapine XR 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Affecta Pskyiatrimottagning" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Affecta Pskyiatrimottagning". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Affecta Pskyiatrimottagning, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Affecta Pskyiatrimottagning, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".